RetinaDigest

Weekly curated literature from top retina and ophthalmology journals

57 articles
9 categories
🔬

Retinal Detachment & Trauma9 articles

RRD, TRD, giant tears, PVR, ocular trauma, macular hole, ERM

THE IMPACT OF POSTERIOR STAPHYLOMA ON CLINICAL OUTCOMES OF HIGH MYOPIC MACULAR HOLE: A Retrospective Cohort Study.

Zheng et al.
RetinaMar 1, 2026

In high myopic macular holes, inverted ILM flap technique achieved superior closure rates compared to ILM peeling across different posterior staphyloma types and grades. Staphyloma morphology significantly influences surgical outcomes and vascular recovery patterns.

View full article

OCT Imaging of Macular Hole Containing a Gas Bubble after Retinal Detachment Repair.

Kiryakoza et al.
Am J OphthalmolMar 1, 2026

Abstract not available — see full article for details.

View full article

Impact of Phacoemulsification on Vitreomacular Traction Release and Complications.

Bala et al.
Am J OphthalmolMar 1, 2026

This retrospective study of 310 eyes found that phacoemulsification does not significantly increase the likelihood or speed of vitreomacular traction (VMT) release, with intrinsic patient factors being more predictive of outcomes.

View full article

Subretinal Fluid Duration and Clinical Outcomes in Central Serous Chorioretinopathy: An Analysis of Time-to-Photodynamic Therapy.

Funatsu et al.
Am J OphthalmolMar 1, 2026

In CSC patients awaiting PDT, prolonged subretinal fluid duration causes progressive outer nuclear layer thinning but does not significantly impact 12-month visual outcomes or treatment success.

View full article

Macular Hole-Related Retinal Detachment in Gyrate Atrophy.

Sharma et al.
RetinaMar 1, 2026

Abstract not available — see full article for details.

View full article

Re: Szeto et al: Macular Hole Closure by Internal Limiting Membrane Flap without Gas Tamponade versus Conventional Surgery.

Iuliano et al.
Ophthalmol RetinaFeb 28, 2026

Abstract not available — see full article for details.

View full article

Long Term Anatomic and Visual Outcomes of Surgery for Rhegmatogenous Retinal Detachment in Young Adult Patients.

Oh et al.
Ophthalmol RetinaFeb 26, 2026

Primary scleral buckle repair for rhegmatogenous retinal detachment in young adults achieves 80.3% single-surgery success at 12 months with favorable long-term visual outcomes, though 26.9% require fellow-eye intervention during follow-up.

View full article

Comparing the Vitreous Floaters Functional Questionnaire to the VFQ-25 in Vision Degrading Myodesopsia from Vitreous Floaters.

Sebag et al.
Am J OphthalmolFeb 24, 2026

The Vitreous Floater Functional Questionnaire (VFFQ-23) significantly outperformed the NEI VFQ-25 in predicting surgical decision-making and measuring post-operative improvement in patients with vision-degrading myodesopsia from vitreous floaters.

View full article

Vertical Henle Fiber Hyperreflective Line and Angular Sign of Henle Fiber Layer Hyperreflectivity After Blunt Ocular Trauma.

Sagurski et al.
Ophthalmol RetinaFeb 24, 2026

Abstract not available — see full article for details.

View full article
🩸

Diabetic Eye Disease6 articles

Diabetic retinopathy surgery, DME treatment, tractional complications

Elevated Retinal Neovascularization on Widefield Optical Coherence Tomography Angiography Predicts Complications in High-Risk Proliferative Diabetic Retinopathy.

Wu et al.
Am J OphthalmolMar 1, 2026

Widefield SS-OCTA-derived metrics of retinal neovascularization burden, particularly elevated RNV lesions separated from the internal limiting membrane, predict vision-threatening complications in high-risk proliferative diabetic retinopathy with high accuracy.

View full article

Association of Patient Age with Response to Anti-Vascular Endothelial Growth Factor Agents for Treatment of Diabetic Macular Edema.

Liu et al.
RetinaMar 1, 2026

Anti-VEGF treatment response for diabetic macular edema significantly decreases with patient age, with older patients showing less visual acuity improvement and higher rates of weak treatment response over 2 years.

View full article

CORRELATION OF RETINAL IMAGING UTILIZATION WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AND PANRETINAL PHOTOCOAGULATION USAGE FROM 2013 TO 2021.

Sheth et al.
RetinaMar 1, 2026

OCT utilization increased significantly from 2013-2021 while fluorescein angiography declined, correlating with increased anti-VEGF injections and decreased panretinal photocoagulation usage in retinal disease management.

View full article

OUTER RETINAL LAYER DETERIORATION PATTERNS IN EYES WITH DIABETIC SEROUS MACULAR DETACHMENT.

Kirik et al.
RetinaMar 1, 2026

This retrospective study identified five distinct outer retinal layer deterioration patterns in diabetic serous macular detachment, with WEDGE pattern showing the best visual prognosis and DIFFUSE pattern having the poorest outcomes.

View full article

Expanded Field Optical Coherence Tomography Angiography Biomarkers Associated with Future Cardiovascular Disease and Mortality in Patients with Diabetic Retinopathy.

Lu et al.
RetinaMar 1, 2026

This study found that specific OCTA biomarkers, including neovascularization vessel density and deep capillary plexus changes, are associated with increased risk of cardiovascular events and mortality in diabetic retinopathy patients.

View full article

Association Between Baseline Glycated Hemoglobin Levels and Functional and Anatomical Outcomes Following Faricimab Loading Phase in Diabetic Macular Edema.

Scampoli et al.
RetinaFeb 24, 2026

In 74 eyes with diabetic macular edema, baseline HbA1c levels showed weak correlation with visual acuity improvement but did not predict faricimab treatment response. Faricimab loading phase demonstrated significant anatomical and functional improvements regardless of glycemic control status.

View full article
👁️

AMD & Macular Degeneration15 articles

Neovascular AMD, geographic atrophy, submacular hemorrhage

Choroidal Macrovessel Complicated by Choroidal Neovascularisation.

Albanese et al.
Am J OphthalmolMar 1, 2026

Abstract not available — see full article for details.

View full article

Pilot Study of Choroidal Synphlebia.

Spaide
RetinaMar 1, 2026

This pilot study describes choroidal synphlebia, a newly recognized choroidal venous phenotype characterized by confluent venous structures ≥750 µm, predominantly associated with central serous chorioretinopathy and potentially explaining treatment-resistant cases.

View full article

A Randomized-Controlled Trial of the Efficacy, Safety and Tolerability of Intravitreal Brolucizumab in Patients With Chronic Central Serous Chorioretinopathy With Persistent Fluid in the Absence of Choroidal Neovascular Membrane-BRICS Trial Report II.

Ramamurthy et al.
Am J OphthalmolMar 1, 2026

This randomized controlled trial demonstrated that intravitreal brolucizumab effectively resolves persistent subretinal fluid in chronic central serous chorioretinopathy without choroidal neovascularization, with 77% of treated eyes achieving >20% reduction in central macular thickness at 1 month.

View full article

Atrophy Advisor: A Clinical Tool for Dry Macular Degeneration With Geographic Atrophy.

Kerwin et al.
Am J OphthalmolMar 1, 2026

Kerwin et al. developed Atrophy Advisor, a clinical decision tool that combines geographic atrophy progression rates and personalized lifespan estimates to guide complement factor inhibitor treatment decisions in dry AMD patients.

View full article

Basal Laminar Deposits and Pseudodrusen: Rethinking Their Role in Age-Related Macular Degeneration Progression.

Fragiotta et al.
RetinaMar 1, 2026

Basal laminar deposits (BLamD) are consistently present in eyes with pseudodrusen and may serve as indicators of AMD severity, potentially contributing to rapidly progressive atrophy when associated with subretinal drusenoid deposits.

View full article

Retinal fingerprint pattern in central serous chorioretinopathy.

Burnasheva et al.
RetinaMar 1, 2026

Retinal fingerprint pattern (RFP) was identified in 18.3% of central serous chorioretinopathy (CSCR) eyes and was associated with greater subretinal fluid height and significantly better anatomical outcomes including higher rates of complete fluid resolution.

View full article

DIAGNOSTIC PERFORMANCE OF MACHINE LEARNING TECHNOLOGY USING OPTICAL COHERENCE TOMOGRAPHIC IMAGE IN RETINAL DISEASES PRESENTED WITH SUBRETINAL FLUID.

Khakhai et al.
RetinaMar 1, 2026

Machine learning analysis of OCT images achieved 87.10% accuracy in differentiating central serous chorioretinopathy, polypoidal choroidal vasculopathy, and Vogt-Koyanagi-Harada disease, with best performance using single foveal OCT scans combined with infrared photography.

View full article

A NOVEL TECHNIQUE FOR SUBRETINAL HEMATOMA MIGRATION: Directing the Lesion Toward Artificial Retinal Detachment.

Goda et al.
RetinaMar 1, 2026

A novel surgical technique demonstrates that subretinal hematomas can be directed away from the fovea by creating an artificial retinal detachment with subretinal tPA injection at a strategic location temporal to the macula.

View full article

OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY BIOMARKERS FOR PREDICTING RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Ucak et al.
RetinaMar 1, 2026

Loop-shaped neovascular morphology on baseline OCTA independently predicted poor anatomical response to anti-VEGF therapy in treatment-naïve neovascular AMD patients. This biomarker may enable early risk stratification and guide personalized treatment approaches.

View full article

Quantifying Effects of Diet and Lifestyle Changes on Progression to Advanced Age and Related Macular Degeneration in High Genetic Risk Individuals.

Seddon et al.
OphthalmologyMar 1, 2026

Among high genetic risk patients with early/intermediate AMD, adopting healthy lifestyle behaviors could prevent 56-60% of progression to advanced AMD, with unhealthy behaviors increasing progression risk 3-5 fold.

View full article

Clinical Characteristics and Outcomes in Central Serous Chorioretinopathy with Subretinal Hyper-Reflective Material: MICRoN report 6.

Sahoo et al.
Am J OphthalmolFeb 26, 2026

Chronic CSCR patients with subretinal hyperreflective material (SHRM) present with worse baseline vision and have higher rates of persistent subretinal fluid and ellipsoid zone loss despite visual improvement after treatment.

View full article

Domain-Shift AI Technology for Vendor-Agnostic Multiple Macular Disease Detection From 3D OCT Scans.

Tang et al.
JAMA OphthalmolFeb 26, 2026

A deep learning model trained exclusively on Spectralis OCT scans demonstrated robust performance for multiple macular disease detection across different OCT vendors (Heidelberg and Zeiss) with AUROC values ranging from 0.754-0.999, achieving high negative predictive values (>97.5%) and manageable miss rates for urgent cases (6-7%).

View full article

Comparison of Initial Loading Injection Outcomes Between Aflibercept 8 mg and Faricimab in Neovascular Age-Related Macular Degeneration.

Han et al.
RetinaFeb 25, 2026

This retrospective study of 100 treatment-naïve neovascular AMD patients found that aflibercept 8 mg and faricimab achieved statistically equivalent visual and anatomical outcomes after three monthly loading injections.

View full article

SD-OCT and OCTA: distinct or additional information on neovascular activity? The COCTAEYL Study.

Amoroso et al.
RetinaFeb 24, 2026

OCTA showed poor diagnostic performance compared to SD-OCT for detecting neovascular AMD recurrence, with sensitivity of 72% but specificity of only 27%, and did not reduce unnecessary injections or change treatment decisions.

View full article

Tomographic biomarkers differ by progression risk to late macular degeneration.

Bernardi et al.
Ophthalmol RetinaFeb 24, 2026

Hyperreflective foci (HRF) and subretinal drusenoid deposits (SDD) show distinct progression patterns in AMD, with HRF increasing risk for both geographic atrophy and neovascular AMD, while SDD increases risk only for geographic atrophy.

View full article
🫀

Vascular Occlusions2 articles

CRVO, BRVO, retinal ischemia, macular edema from RVO

CHOROIDAL VASCULARITY INDEX, RETINAL VASCULARITY, AND HEMOGLOBIN LEVELS IN PEDIATRIC SICKLE CELL MACULOPATHY.

Chaaya et al.
RetinaMar 1, 2026

Pediatric sickle cell disease patients showed significantly reduced choroidal vascularity index (54% vs 69% in controls) that correlated with decreased retinal vessel density and lower hemoglobin levels, suggesting choroidal ischemia contributes to sickle cell maculopathy pathogenesis.

View full article

Association between Retinal Vein Occlusion and Epiretinal Membrane Development.

Almosa et al.
Am J OphthalmolFeb 24, 2026

Epiretinal membrane (ERM) formation peaks within 3 months after retinal vein occlusion (RVO), with highest surgical intervention rates occurring at 1 year for BRVO and 3 years for CRVO in untreated eyes.

View full article
🧬

Inherited Retinal Disease7 articles

IRDs, gene therapy, retinitis pigmentosa, LCA, Stargardt

ROLE OF INFLAMMATION IN ATROPHY DEVELOPMENT AND PROGRESSION IN PATHOLOGIC MYOPIA.

Gilead et al.
RetinaMar 1, 2026

In pathologic myopia, prior retinal inflammation consistent with punctate inner choroidopathy significantly accelerates atrophic progression, doubling the annual atrophy expansion rate compared to non-inflamed controls.

View full article

Natural History of CNGA1-Associated Retinitis Pigmentosa in a Large Chinese Cohort Revealing an Optimal Intervention Window.

Liu et al.
Am J OphthalmolMar 1, 2026

This large Chinese cohort study of 58 CNGA1-associated retinitis pigmentosa patients identified a distinct natural history pattern with visual acuity remaining stable until age 30.7 years before declining, while visual field loss occurs earlier, suggesting an optimal intervention window between the 3rd and 4th decades of life.

View full article

Autosomal Recessive Bestrophinopathy-Phenotypic Variability, Natural History, and Genotype-Phenotype Correlations.

Bianco et al.
Am J OphthalmolMar 1, 2026

Autosomal recessive bestrophinopathy shows wide phenotypic variability from mild macular involvement to severe panretinal degeneration, but visual impairment risk is primarily driven by primary angle closure rather than fundus lesion severity.

View full article

EARLY FINDINGS FROM A NATURAL HISTORY STUDY OF PATIENTS WITH THE PATHOGENIC p.Gly208Asp PRPH2 VARIANT ASSOCIATED WITH RETINAL DYSTROPHY.

AlAshwal et al.
RetinaMar 1, 2026

This prospective study of 7 patients with the pathogenic p.Gly208Asp PRPH2 variant demonstrates significant retinal thinning and expansion of atrophic areas over 1 year, establishing multimodal imaging markers for monitoring central areolar chorioretinal dystrophy progression.

View full article

CLINICAL FEATURES OF MERTK -RELATED RETINOPATHY.

Khan
RetinaMar 1, 2026

MERTK-related retinopathy presents as juvenile rod-cone dystrophy with early macular involvement, typically causing significant visual loss by teenage years with characteristic asymmetric central macular atrophy.

View full article

Capturing the Mizuo-Nakamura Phenomenon with Ultra-Widefield Fundus Photography.

Cardoso et al.
Ophthalmol RetinaFeb 26, 2026

Abstract not available — see full article for details.

View full article

Progression in X-Linked Retinoschisis: A Longitudinal Study Defining Quantitative Biomarkers and Their Implications for Gene Therapy.

Wei et al.
Am J OphthalmolFeb 25, 2026

This longitudinal study of 107 XLRS patients demonstrates a triphasic pattern of visual decline with optimal therapeutic window in early adulthood, and validates automated cyst-cavity volume as a quantitative biomarker for monitoring disease progression.

View full article
👶

Pediatric Retina4 articles

ROP, FEVR, Coats disease, retinoblastoma, pediatric vitreoretinal

EFFICACY AND VASCULAR REDEVELOPMENT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR STAGE 2 EARLY-DIAGNOSED FAMILIAL EXUDATIVE VITREORETINOPATHY.

Ma et al.
RetinaMar 1, 2026

Anti-VEGF therapy effectively treated 79% of stage 2 FEVR cases diagnosed under 3 months of age and promoted continued peripheral vascular growth, with most eyes showing regression of vascular activity.

View full article

Progressive Vascular Malformation at the Optic Disc in a Pediatric Patient.

Alshalan et al.
OphthalmologyMar 1, 2026

Abstract not available — see full article for details.

View full article

Hyperacute Outer Retinal Dysfunction in a Child.

Ehrenberg et al.
JAMA OphthalmolFeb 26, 2026

Abstract not available — see full article for details.

View full article

Re: Barresi et al: Surgical and Observational Outcomes in Optic Pit Maculopathy: A Comparative Analysis of Pediatric and Adult Populations (Ophthalmol Retina. 2026;10:445-454).

Shukla
Ophthalmol RetinaFeb 26, 2026

Abstract not available — see full article for details.

View full article
🔥

Posterior Uveitis7 articles

Posterior uveitis, panuveitis, chorioretinitis, CMV retinitis, ocular inflammation

Focal Choroidal Excavation Associated With Eales Disease.

Pramil et al.
RetinaMar 1, 2026

Abstract not available — see full article for details.

View full article

Interpreting Imaging in the Era of Artificial Intelligence: Future Possibilities in Ocular Inflammatory Disease.

McKay et al.
Am J OphthalmolMar 1, 2026

This review examines the emerging applications of artificial intelligence in uveitis diagnosis and monitoring, highlighting AI's potential to automate multimodal imaging interpretation and improve clinical efficiency in ocular inflammatory disease management.

View full article

Factors Associated with Ocular Relapse and Visual Prognosis in Sarcoid Uveitis.

Abramowicz et al.
OphthalmologyMar 1, 2026

In this multicenter study of 336 sarcoid uveitis patients, ocular relapses occurred in two-thirds of patients with macular edema and persistent inflammation at baseline predicting shorter relapse-free survival, while visual impairment remained low at 6.5% after median 7.8-year follow-up.

View full article

Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial.

et al.
OphthalmologyMar 1, 2026

The ADVISE trial demonstrated that adalimumab was superior to conventional immunosuppression for achieving corticosteroid sparing at 6 months and corticosteroid discontinuation at 12 months in patients with noninfectious intermediate, posterior, or panuveitis.

View full article

Comparative Clinical Features, Vascular Complications, and Outcomes in CMV Retinitis: Pediatric vs HIV Positive and HIV Negative Adults.

Bezci Aygun et al.
Ocul Immunol InflammFeb 24, 2026

This retrospective study of 41 patients with CMV retinitis found that pediatric patients demonstrate more severe disease with higher rates of bilateral involvement, extensive retinal damage, and retinal detachment compared to HIV-positive and HIV-negative adults.

View full article

Characteristics Associated with Appointment No-Show at an Academic Uveitis Service.

Kong et al.
Ocul Immunol InflammFeb 24, 2026

This retrospective study of 1,081 uveitis patients found that 36.4% had at least one no-show appointment, with younger age, Black race, Medicaid insurance, and blindness being significant risk factors for missed appointments.

View full article

Resurgence of Ocular Syphilis: HIV Co-Infection, Clinical Manifestations, and High-Risk Sexual Behaviour in an Indonesian Cohort.

Susiyanti et al.
Ocul Immunol InflammFeb 24, 2026

This Indonesian cohort study of 47 ocular syphilis patients found a 9:1 male predominance with 78.7% HIV co-infection, particularly among men who have sex with men, and demonstrated more severe ocular inflammation in HIV-positive patients.

View full article
🎯

Ocular Oncology2 articles

Uveal melanoma, retinoblastoma, choroidal tumors, ocular metastases

Retinal Pigment Epithelium Disruption Lesions on Optical Coherence Tomography in Patients With Vitreoretinal Lymphoma.

Chen et al.
Am J OphthalmolMar 1, 2026

RPE disruption lesions on OCT are frequently occurring yet underrecognized findings in vitreoretinal lymphoma, present in 78% of affected eyes and potentially serving as diagnostic clues for VRL identification.

View full article

Safety Assessment of Aqueous Humor Liquid Biopsy in Retinoblastoma: A Multicenter Study of 1203 Procedures.

Chigane et al.
OphthalmologyMar 1, 2026

Aqueous humor liquid biopsy via anterior chamber paracentesis demonstrated exceptional safety in retinoblastoma patients, with only 1 mild complication among 1,203 procedures (0.08% complication rate) and no severe adverse outcomes.

View full article
⚠️

Complications & Safety5 articles

Endophthalmitis, surgical complications, drug safety, adverse events

Potential Eye Disorders in People With and Without Type 2 Diabetes Mellitus Exposed to GLP-1 Receptor Agonists: An Examination of the FAERS (FDA Adverse Event Reporting System) Database.

Murray et al.
Am J OphthalmolMar 1, 2026

FAERS database analysis revealed increased reporting of various eye disorders, including retinopathy, cataracts, and optic ischemic neuropathy, associated with GLP-1 receptor agonists compared to metformin in both diabetic and non-diabetic patients.

View full article

Pathogen-Associated Visual Outcomes Following Postprocedure Endophthalmitis.

Ather et al.
Am J OphthalmolMar 1, 2026

In postprocedural acute endophthalmitis, infections with virulent nonsurface commensal organisms (Streptococcus, Enterococcus) result in significantly worse visual outcomes and higher complication rates compared to coagulase-negative Staphylococcus infections.

View full article

Clinical and microbiological characteristics of multidrug-resistant acute bacterial endophthalmitis after cataract surgery. Endophthalmitis Management Study Report # 8.

Das et al.
RetinaMar 1, 2026

Multidrug-resistant bacterial endophthalmitis after cataract surgery occurs in 7.8% of cases, predominantly caused by gram-negative bacilli, with colistin showing superior efficacy compared to other antibiotics for treatment.

View full article

Ocular Hypertension and Glaucoma After Pars Plana Vitrectomy: A Systematic Review and Meta-Analysis.

Gallo Afflitto et al.
OphthalmologyMar 1, 2026

This meta-analysis of 54,006 patients found that pars plana vitrectomy increases the risk of ocular hypertension (5.6%) and glaucoma (3.9%), with pseudophakic eyes having substantially higher odds of developing these complications compared to phakic eyes.

View full article

Generalizability in OCT Deep Learning-Moving Beyond Single-Disease and Single-Vendor Models.

Liu et al.
JAMA OphthalmolFeb 26, 2026

Abstract not available — see full article for details.

View full article